HomeInsightsStock Comparison

Rpg Life Sciences Ltd vs Sun Pharmaceutical Industries Ltd Stock Comparison

Rpg Life Sciences Ltd vs Sun Pharmaceutical Industries Ltd Stock Comparison

Last Updated on: Dec 20, 2025

Key Highlights

  • The Latest Trading Price of RPG Life Sciences Ltd is ₹ 2346 as of 19 Dec 15:30.
  • The P/E Ratio of RPG Life Sciences Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 22.5 on March 2020 to 38.1 on March 2025 . This represents a CAGR of 9.18% over 6 years.
  • The Market Cap of RPG Life Sciences Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Sun Pharmaceutical Industries Ltd changed from ₹ 84504 crore on March 2020 to ₹ 416392 crore on March 2025 . This represents a CAGR of 30.45% over 6 years.
  • The revenue of RPG Life Sciences Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sun Pharmaceutical Industries Ltd for the Sep '25 is ₹ 14948 crore as compare to the Jun '25 revenue of ₹ 14315 crore. This represent the growth of 4.42%.
  • The ebitda of RPG Life Sciences Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sun Pharmaceutical Industries Ltd for the Sep '25 is ₹ 4996 crore as compare to the Jun '25 ebitda of ₹ 3948 crore. This represent the growth of 26.57%.
  • The net profit of RPG Life Sciences Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% The net profit of Sun Pharmaceutical Industries Ltd changed from ₹ 2013 crore to ₹ 3137 crore over 10 quarters. This represents a CAGR of 19.42% .
  • The Dividend Payout of RPG Life Sciences Ltd changed from 24.66 % on March 2020 to 21.66 % on March 2025 . This represents a CAGR of -2.14% over 6 yearsThe Dividend Payout of Sun Pharmaceutical Industries Ltd changed from 29.89 % on March 2020 to 89.64 % on March 2025 . This represents a CAGR of 20.09% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About RPG Life Sciences Ltd

  • RPG Life Sciences Limited, formerly known as Searle India Limited, started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to RPG Group.
  • The Company is engaged in manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). RPG Life Sciences Limited was incorporated on March 29, 2007 with the name 'RPG Pharmaceuticals Limited'.
  • During the year 2007-08, as per the Scheme of Arrangement, the Company acquired the Pharmaceuticals Business of Brabourne Enterprises Limited along with all assets and liabilities pertaining to that business with effect from April 2, 2007.
  • On February 13, 2008, the name of the Company was changed to RPG Life Sciences Limited. During the year 2008-09, the company increased the production capacity of Bulk Drugs and Chemicals from 62 tonnes to 71 tonnes.

About Sun Pharmaceutical Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

RPG Life Sciences Ltd News Hub

News

RPG Life Sciences schedules board meeting

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 17 Octob...

Read more

11 Oct 2025 10:08

News

RPG Life Sciences to conduct board meeting

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 25 July ...

Read more

19 Jul 2025 10:29

News

RPG Life Sciences schedules AGM

RPG Life Sciences announced that the 18th Annual General Meeting(AGM) of the company will ...

Read more

16 Jun 2025 15:14

News

Board of RPG Life Sciences recommends special dividend

RPG Life Sciences announced that the Board of Directors of the Company at its meeting held...

Read more

29 Apr 2025 09:35

News

Board of RPG Life Sciences recommends final dividend

RPG Life Sciences announced that the Board of Directors of the Company at its meeting held...

Read more

29 Apr 2025 09:35

News

RPG Life edges higher after Q4 PAT rises 64% YoY to nearly Rs 22 crore

Net sales rose by 12.7% year-over-year (YoY) to Rs 143.09 crore during the period under re...

Read more

29 Apr 2025 11:35

Sun Pharmaceutical Industries Ltd News Hub

News

USFDA classifies Sun Pharma's Baska facility inspection as Official Action Indicated

Sun Pharmaceutical Industries announced that the US FDA conducted an inspection at the Com...

Read more

18 Dec 2025 09:19

News

Sun Pharma declines after US FDA classifies Baska facility inspection as OAI

The American drug regulator had inspected the company's facility from 8 September 2025 to ...

Read more

18 Dec 2025 11:55

News

Sun Pharma launches innovative drug ILUMYA (Tildrakizumab) in India

Sun Pharmaceutical Industries announced the launch of its global innovative drug, ILUMYA (...

Read more

01 Dec 2025 13:19

News

Sun Pharmaceutical Industries Ltd up for fifth session

Sun Pharmaceutical Industries Ltd is up for a fifth straight session in a row. The stock i...

Read more

13 Nov 2025 13:00

News

Sun Pharma records PAT of Rs 3,118 crore in Q3

Formulation sales in India were Rs 4,734.8 crore, registering a growth of 11%. India Formu...

Read more

06 Nov 2025 11:18

News

Sun Pharmaceutical Industries Ltd up for third consecutive session

Sun Pharmaceutical Industries Ltd is up for a third straight session today. The stock is q...

Read more

17 Oct 2025 13:05

SWOT Analysis Of Sun Pharmaceutical Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of RPG Life Sciences Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Sun Pharmaceutical Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for RPG Life Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of RPG Life Sciences Ltd and Sun Pharmaceutical Industries Ltd

Which company has a larger market capitalization, RPG Life Sciences Ltd or Sun Pharmaceutical Industries Ltd?

Market cap of RPG Life Sciences Ltd is 3,881 Cr while Market cap of Sun Pharmaceutical Industries Ltd is 418,707 Cr

What are the key factors driving the stock performance of RPG Life Sciences Ltd and Sun Pharmaceutical Industries Ltd?

The stock performance of RPG Life Sciences Ltd and Sun Pharmaceutical Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for RPG Life Sciences Ltd and Sun Pharmaceutical Industries Ltd?

As of December 20, 2025, the RPG Life Sciences Ltd stock price is INR ₹2346.95. On the other hand, Sun Pharmaceutical Industries Ltd stock price is INR ₹1745.1.

How do dividend payouts of RPG Life Sciences Ltd and Sun Pharmaceutical Industries Ltd compare?

To compare the dividend payouts of RPG Life Sciences Ltd and Sun Pharmaceutical Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions